I won't go as far as calling you a basher, but I w

I won't go as far as calling you a basher, but I was a bit uncertain after reading your first post and I still have my doubts. The typical soft bash of AMBS is "hey, I'm new around here and I love MANF, but don't think much of Lympro." You've now expressed that sentiment in several posts. So maybe I am going as far as calling you a basher.

In my opinion, if you own shares and are comfortable with your investment, there really is no sense in worrying about Lympro anymore. We're so close to hearing news on data, partner, etc that you might as well just hold on and see what happens. To use one of my favorite cliches, "the hay is in the barn" (or pretty close to it).

There are two reasons the stock price isn't higher right now. Data has been delayed and interim data was misinterpreted by the market. Now, the market is hesitant until the final numbers come out. Without the delay and subsequent misinterpretation of data, the pps would be twice it's current number.

That's just my opinion. It's your money. If you are really that worried about Lympro, why did you buy shares now? If your answer is "I'm here for MANF," that's great, but then stop worrying about Lympro and let it play out.